Severity of HCV-Induced Liver Damage Alters Glucose Homeostasis in Noncirrhotic Patients with Chronic HCV Infection

By  

Digestion, Vol. 62, Iss. 1, 2000-07 ,pp. : 52-59

Karger

Access to resources Recommend Favorite

Chronic Hepatitis C and Crohn’s Disease: Nosocomial Infection Treatment with PEG-Interferon plus Ribavirin

By  

Digestion, Vol. 73, Iss. 4, 2006-09 ,pp. : 210-214

Karger

Access to resources Recommend Favorite

YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection

By Schiavon Leonardo L.   Carvalho-Filho Roberto J.   Narciso-Schiavon Janaína L.   Medina-Pestana José O.   Lanzoni Valéria P.   Ferraz Maria Lucia G.   Silva Antonio Eduardo B.  

Scandinavian Journal of Gastroenterology, Vol. 45, Iss. 5, 2010-05 ,pp. : 615-622

Informa Healthcare

Access to resources Recommend Favorite

Predictive Factors for Response to Peginterferon-Alpha and Ribavirin Treatment of Chronic HCV Infection in Patients Aged 65 Years and More

By Giannini Edoardo   Basso Monica   Savarino Vincenzo   Picciotto Antonino  

Digestive Diseases and Sciences, Vol. 55, Iss. 11, 2010-11 ,pp. : 3193-3199

Springer Publishing Company

Access to resources Recommend Favorite

Early Decision: Effector and Effector Memory T Cell Differentiation in Chronic Infection

By  

Current Immunology Reviews, Vol. 9, Iss. 3, 2013-08 ,pp. : 190-206

Bentham Science Publishers

Access to resources Recommend Favorite